Suchergebnisse - "Kubota, Ryuji"

PubPharm (200)

1

Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor

enthalten in: Infectious diseases and therapy | 2024

von Katsube, T. | Kezbor, S. | Shimizu, R. | +1

2

Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor

enthalten in: Infectious diseases and therapy | 2024

von Katsube, T. | Kezbor, S. | Shimizu, R. | +1

3

Clinical features, future cardiac events, and prognostic factors following percutaneous coronary intervention in young female patients

enthalten in: Heart and vessels | 2024

von Tatami, Y. | Tanaka, A. | Ohashi, T. | +17

4

Geographic characteristics of HTLV-1 molecular subgroups and genetic substitutions in East Asia : Insights from complete genome sequencing of HTLV-1 strains isolated in Taiwan and Japan

enthalten in: PLoS neglected tropical diseases | 2024

von Nozuma, S. | Yoshimura, A. | Pai, S. | +9

5

Performance evaluation of Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test for different diagnostic situations

enthalten in: Microbiology spectrum | 2023

von Kuramitsu, M. | Momose, H. | Uchida, Y. | +26

6

A Phase 1 Study of Ensitrelvir Fumaric Acid Tablets Evaluating the Safety, Pharmacokinetics and Food Effect in Healthy Adult Populations

enthalten in: Clinical drug investigation | 2023

von Shimizu, R. | Sonoyama, T. | Fukuhara, T. | +3

7

A Phase 1 Study of Ensitrelvir Fumaric Acid Tablets Evaluating the Safety, Pharmacokinetics and Food Effect in Healthy Adult Populations

enthalten in: Clinical drug investigation | 2023

von Shimizu, R. | Sonoyama, T. | Fukuhara, T. | +3

8

Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects : A phase 1 clinical trial

enthalten in: Neuropsychopharmacology reports | 2023

von Sonoyama, T. | Shimizu, R. | Kubota, R. | +6

9

Evaluation of Drug-Drug Interactions of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical Studies

enthalten in: Journal of clinical pharmacology | 2023

von Shimizu, R. | Matsuzaki, T. | Oka, R. | +5

10

Population pharmacokinetics of duloxetine in Japanese pediatric patients with major depressive disorder

enthalten in: Drug metabolism and pharmacokinetics | 2023

von Shibata, R. | Kubota, R. | Uenaka, K. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]